Description
CJC-1295 (without DAC) combined with Ipamorelin is a synergistic peptide formulation designed for controlled research environments that require precise modulation of growth hormone (GH) release. This blend pairs a short-acting GHRH analog with a selective GH secretagogue, enabling researchers to study both pituitary stimulation pathways simultaneously with enhanced experimental flexibility.
CJC-1295 (without DAC) provides rapid, transient GHRH activity, while Ipamorelin contributes highly specific GH pulse signaling with minimal interference on cortisol or prolactin. Together, they are used in studies focusing on GH pulsatility, pituitary responsiveness, and metabolic signaling pathways.
Purity: ≥ 99% (HPLC verified)
Form: Lyophilized peptide powder
Quantity: 5 mg per vial
Storage:
-
Lyophilized: store at −20 °C
-
After reconstitution: refrigerate at 2–8 °C
Intended Use:
For laboratory research only — not for human consumption.
Key Features
-
Short-acting GHRH analog paired with a selective GH secretagogue
-
Designed for studies requiring controlled GH pulse patterns
-
High purity with reliable batch-to-batch consistency
-
Manufactured in a cGMP-compliant facility
-
COA available upon request
Disclaimer:
This product is intended strictly for laboratory research use only. Not for human use, medical use, or diagnostic applications.





Reviews
There are no reviews yet.